Albumin Market Set To Reach USD 11.02 Billion By 2032, Driven By Rising Therapeutic Applications And Expanding Healthcare Demand SNS Insider

(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider Unveils Strategic Insights into the U.S. Albumin Market's Robust Growth-Valued at USD 4.35 Billion in 2023-As the Nation Continues to Lead Global Therapeutic Utilization Amid Advanced Biotech Integration

Austin, June 10, 2025 (GLOBE NEWSWIRE) -- Albumin Market Size & Growth Analysis:

According to SNS Insider, the global Albumin Market was valued at USD 6.65 billion in 2023 and is projected to reach USD 11.02 billion by 2032, growing at a CAGR of 6.58% during the forecast period of 2024–2032.

The albumin market is growing steadily, supported by the increased need for albumin in therapeutics, diagnostics, and research. Rising incidence of liver and kidney diseases, production development of recombinant albumin are driving the growth. This is largely driven by the pharmaceutical and biotechnology industries, whose increasing global healthcare demands and clinical applications continue to reinforce and expand market share.

Get a Sample Report of Albumin Market@

The U.S. albumin market was estimated at USD 4.35 billion in 2023 and is expected to reach USD 6.97 billion by 2032, at a CAGR of 6.13% during the forecast period of 2024-2032. North America held the largest share of the global albumin market for 2024, owing to well-established healthcare infrastructure, extensive research and development capabilities, and high adoption of albumin in clinical settings and continued high demand for albumin products in the United States due to diversified therapeutic applications, along with the country stable plasma collection network.

Major Players Analysis Listed in this Report are:

• CSL Limited
• Grifols S.A.
• Octapharma AG
• Baxter International Inc.
• Takeda Pharmaceutical Company Limited
• China Biologic Products Holdings Inc.
• Kedrion Biopharma Inc.
• Hualan Biological Engineering Inc.
• Biotest AG
• Shanghai RAAS Blood Products Co. Ltd.
• Other players

Albumin Market Report Scope

Report Attributes	Details
Market Size in 2024	US$ 6.65 billion
Market Size by 2032	US$ 11.02 billion
CAGR	CAGR of 6.58% From 2025 to 2032
Base Year	2024
Forecast Period	2025-2032
Historical Data	2021-2023
Regional Analysis	North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)

Segment Analysis

Human Serum Albumin Segment Dominated the Albumin Market by Product

Human serum albumin segment dominates the albumin market in 2024 with a 54.6% market share, owing to its major application in the treatment of various medical conditions such as liver cirrhosis, burns, shock, and hypoalbuminemia. Due to its favorable safety profile, biocompatibility, effectiveness in volume resuscitation, and delivery of therapeutics, it is used extensively in the clinical arena. The demand from the hospital and surgical center markets has driven growth in this segment, along with availability due to new plasma fractionation facilities.

By Application, Therapeutics Segment Dominates the Albumin Market

The therapeutics segment dominated the market with 68.1% market share in 2024, owing to the high application of albumin in the treatment of critical medical conditions like liver diseases, trauma, burns, and shock. It is a vital component of emergency and surgical care, having a key role as a plasma volume expander and stabilizer in several life-saving treatments. Its demand was also driven by an increase in chronic diseases and a rise in hospitalization rates.

The Hospitals & Clinics Segment Dominates the Albumin Market by End-User

The albumin market was dominated by the hospitals & clinics segment, capturing around 82.2% market share in 2024, and this is due to a high number of patient admissions for the diseases where albumin therapy is administered, like liver failure, burns, trauma, and major surgeries. They are major sites for emergency and critical care facilities where human serum albumin is commonly administered for either plasma volume expansion or protein replacement.

For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@

Albumin Market Segmentation

By Product

• Human Serum Albumin
• Recombinant Albumin
• Bovine Serum Albumin

By Application

• Therapeutics
• Diagnostics
• Research

By End-user

• Hospital & Clinics
• Pharmaceutical & Biotechnology Industry
• Research Institutes

Regional Trends

The Albumin Market is Dominated by North America, While the Asia Pacific Region is Expected to Register the Fastest Growth.

In 2024, North America had the highest share of the albumin market with 43.4% market share, owing to the well-developed healthcare infrastructure, extensive clinical research, and extensive utilization of albumin for any type of liver, kidney, and cardiovascular disorders. The region is aided by the presence of key manufacturers of plasma-derived therapy products, relatively high levels of awareness, and significant governmental support. Ongoing biotechnological investments and higher utilization of albumin in surgery, trauma, and therapy applications have enabled North America to maintain its dominance in this sector.

The albumin market in Asia Pacific is expected to register the fastest growth, due to improving economic conditions, increasing healthcare expenditure, rising cases of chronic liver and kidney disease, and growing demand for low-cost therapeuticsexpected to growth observative period. China and India are increasing their plasma collection and manufacturing, and healthcare reforms are increasing access to advanced therapies.

Buy a Single-User PDF of Albumin Market Analysis & Outlook Report 2024-2032@

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Albumin Market by Product

8. Albumin Market by Application

9. Albumin Market by End-user

10. Regional Analysis

11. Company Profiles

12. Use Cases and Best Practices

13. Conclusion

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: ...

MENAFN10062025004107003653ID1109656277